Clinical Trials on SARS Pneumonia

Total 10316 results

Bioaraba Health Research Institute
Fundación Eduardo Anitua

Completed

Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.

SARS Pneumonia | SAR

Spain
University of Missouri-Columbia

Completed

Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth

SARS-CoV 2 | SARS Pneumonia

United States
University of Texas Southwestern Medical Center

Terminated

Cardiovascular Implications of COVID-19

COVID-19 | SARS-CoV 2 | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | Cardiac Complication | SARS Pneumonia

United States
Hospital Departamental de Villavicencio
Cooperative University of Colombia; Clinica Primavera; Clínica Meta; Grupo de Investigación...

Withdrawn

Characteristics of Patients With COVID-19 in Meta State, Colombia

SARS-CoV 2 | COVID | SARS (Severe Acute Respiratory Syndrome) | SARS (Disease) | SARS Pneumonia
Collegium Medicum w Bydgoszczy

Recruiting

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation (DANTE-SIRIO 8)

SARS-CoV2 Infection | SARS-CoV2 Antibodies

Poland
BioNTech SE

Completed

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

COVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)

United States, Germany, Turkey, South Africa
Collegium Medicum w Bydgoszczy

Active, not recruiting

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study (DANTE-SIRIO 7)

SARS-CoV2 Infection | SARS-CoV2 Antibodies

Poland
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Unknown

Long-term Evolution of Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Follow the Covid Study

SARS-COV-2 Pneumonia

Italy
Azienda Ospedaliero, Universitaria Pisana

Unknown

Baricitinib Compared to Standard Therapy in Patients With COVID-19 (BARICIVID-19)

Covid-19 | SARS-CoV 2 | SARS Pneumonia

Italy
Boston University
National Institute of Allergy and Infectious Diseases (NIAID); Burnet Institute and other collaborators

Recruiting

COVID-19 Transmission and Morbidity in Malawi (COVID-TMM)

SARS CoV 2 Infection | SARS CoV 2 Vaccination

United States, Malawi
Rigel Pharmaceuticals

Completed

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Pneumonia, Viral | Pneumonia | Covid19 | SARS (Severe Acute Respiratory Syndrome) | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | SARS Pneumonia

United States, Argentina, Brazil, Mexico
ProgenaBiome
Rinati Skin, LLC

Withdrawn

A Study of ResCure™ to Treat COVID-19 Infection

Covid-19 | COVID | Corona Virus Infection | Sars-CoV2 | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | SARS Pneumonia | Coronavirus-19

United States
St. Olavs Hospital
The Research Council of Norway; Helse Nord-Trøndelag HF; Alesund Hospital; Namsos... and other collaborators

Completed

The Corona Study of Middle Norway (CUT COVID-19)

SARS-CoV-2 Acute Respiratory Disease | SARS-CoV-2 Sepsis | SARS CoV 2 Infection

Norway
Instituto Nacional de Enfermedades Respiratorias

Terminated

Glycine Supplement for Severe COVID-19

COVID-19 | Pneumonia, Viral | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome) | ARDS, Human | SARS Pneumonia

Mexico
ProgenaBiome
Big Corona Ltd.

Withdrawn

A Study of Combination Therapies to Treat COVID-19 Infection

COVID-19 | Coronavirus Infection | SARS-CoV 2 | COVID | Corona Virus Infection | SARS Pneumonia | Coronavirus-19 | Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere

United States
Università Politecnica delle Marche
Azienda Ospedaliera Ospedali Riuniti Marche Nord

Unknown

Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis

SARS Pneumonia

Italy
University of Bologna

Unknown

Predictors of Respiratory Failure in SARS-Cov-2 Infection

SARS-CoV-2 Pneumonia

Italy
Grupo Mexicano para el Estudio de la Medicina Intensiva
Instituto Nacional de Enfermedades Respiratorias; National Institute of Pediatrics... and other collaborators

Completed

Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial (CPC-SARS)

SARS Pneumonia

Mexico
University of Virginia

Completed

Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia

Pneumonia | SARS-CoV 2 | Corona Virus Infection | SARS Pneumonia

United States
Hospital Italiano de Buenos Aires

Completed

Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia (PLASM-AR)

COVID-19 | SARS-CoV-2 | SARS Virus

Argentina
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
University Hospital, Lille

Completed

Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19 (MICROVID)

Sars-CoV2

France
Synlab Holding Deutschland GmbH

Completed

COVAG - Covid-19 Antigen Study - the Diagnostic Efficacy of SARS-CoV-2 Rapid Detection Tests (COVAG)

COVID-19 | SARS-CoV2 Infection | SARS (Disease)

Germany
Chulalongkorn University
Ramathibodi Hospital; Ministry of Health, Thailand; The Government Pharmaceutical... and other collaborators

Completed

Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody Cocktail

SARS-CoV-2 Acute Respiratory Disease | SARS CoV 2 Infection

Thailand
Azienda Ospedaliera Universitaria Integrata Verona
Charite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaborators

Recruiting

Follow-up of Covid-19 Long Term Sequelae

Coronavirus Infections | Covid19 | Coronavirus Disease 2019 | Corona Virus Infection | Coronavirus | SARS-CoV2 Infection | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | SARS (Severe Acute Respiratory Syndrome) | COVID-19 Respiratory Infection | SARS (Disease) | COVID-19 Acute Respiratory Distress... and other conditions

Italy, Belgium, Congo, France, Netherlands, Spain
Ascletis Pharmaceuticals Co., Ltd.

Not yet recruiting

Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients

SARS CoV 2 Infection

United States
International Vaccine Institute
Heidelberg University; International Centre for Diarrhoeal Disease Research... and other collaborators

Recruiting

Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique

Sars-CoV-2 Infection

Mozambique
Colorado School of Public Health
University of Colorado, Denver; University of Colorado, Boulder; Colorado State... and other collaborators

Recruiting

Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant Setting

COVID-19 | SARS-CoV2 Infection

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

LIPId Profile Changes in Inflammatory Conditions Induced by SARS-CORoronavirus-2 (LIPICOR)

SARS-CoV2 Infection

France
Beijing 302 Hospital

Not yet recruiting

A Trial of Novaferon in Asymptomatic or Mild COVID-19 Patients

SARS-CoV2 Infection
Jens D Lundgren, MD
Ministry of the Interior and Health, Denmark

Completed

A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.

SARS CoV 2 Infection

Denmark
Barcelona Institute for Global Health
Hospital del Mar; Hospital Universitario Infanta Leonor; Eduardo Mondlane University and other collaborators

Active, not recruiting

SARS-CoV-2 and Acetylsalicylic Acid (SARA) (SARA)

Covid19 | SARS-CoV2 Infection

Spain, Mozambique
Hipra Scientific, S.L.U
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta; Fundación FLS... and other collaborators

Completed

A Phase III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.

SARS CoV 2 Infection

Spain, Turkey
Dompé Farmaceutici S.p.A

Completed

Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

SARS CoV 2 Infection

France, Spain, Italy
Rutgers, The State University of New Jersey
National Institute of Dental and Craniofacial Research (NIDCR)

Completed

Rutgers Pilot for PREDICT- Patient LAB Test

SARS-CoV2 Infection

United States
The Hospital for Sick Children

Completed

The School SPIT Study - Elementary Schools in Low COVID-19 Incidence Regions

SARS-CoV2 Infection

Canada
Collegium Medicum w Bydgoszczy

Completed

Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19 (IMPACT-SIRIO 5)

Sars-CoV-2 Infection

Poland
Sona Nanotech Inc
Nova Scotia Health Authority

Completed

Clinical Evaluation of the SONA Saliva C-19 Rapid Self-Test for the Detection of COVID-19

Sars-CoV-2 Infection

Canada
IRCCS Sacro Cuore Don Calabria di Negrar

Active, not recruiting

Viral Load Analysis of the SARS-CoV-2 Virus in Nose Versus Mouth Sites

Sars-CoV-2 Infection

Italy
Chinese University of Hong Kong

Terminated

Novel SARS-CoV-2 Point-of-care Testing

SARS-CoV2 Infection

Hong Kong
AIDAR Health, Inc.
MAXIS, LLC

Withdrawn

AIDI - Research & Development of a Multisensor-Based Machine Learning Technology for Real-Time Automated Detection of COVID-19 Decompensation (AIDI)

Sars-CoV-2 Infection

United States
Larissa University Hospital

Completed

Effect of Nasopharyngeal Wash With Normal Saline on SARS-CoV2 Viral Load

SARS-CoV2 Infection

Greece
Enanta Pharmaceuticals, Inc

Completed

A Study of EDP-235 in Healthy Subjects

SARS CoV 2 Infection

United States
MiCo BioMed Co., Ltd.
Syntactx

Completed

TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood

SARS-CoV2 Infection

United States
Hôpital Universitaire Sahloul

Completed

Nigella 5 in the Treatment of SARS COV2 (COVID-19) (Nigelle5)

SARS-CoV2 Infection

Tunisia
PT Bio Farma
Sinovac Life Sciences Co., Ltd.; Faculty of Medicine Universitas Padjadjaran; National Intitute of Health Research and Development, Ministry of Health Republic of Indonesia

Completed

Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine (COVID-19)

SARS-CoV2 Infection

Indonesia
HyperSpectral APD

Suspended

Validation of HyperDetector for SARS-CoV-2

SARS-COV2 Infection

United States
University Hospital, Montpellier

Withdrawn

Risk of SARS-CoV-2 Infection (COVID-19) in a Standing Concert in a Closed Performance Hall (ConcerTest)

SARS-CoV-2
Complejo Hospitalario Universitario de Albacete

Recruiting

Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19). (COVIDIOL)

SARS-CoV 2 Pneumonia

Spain
Hipra Scientific, S.L.U
Veristat, Inc.; Asphalion; VHIR

Recruiting

Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.

SARS CoV 2 Infection

Spain

Clinical Trials on SARS Pneumonia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations